Born J, Unseld U, Pietrowsky R, Bickel U, Voigt K, Fehm H L
Angewandte Physiologie, Innere Medizin I, Universität Ulm, FRG.
Neuroendocrinology. 1990 Aug;52(2):169-74. doi: 10.1159/000125569.
Previous studies have demonstrated that the adrenocorticotropic hormone (ACTH) and its 4-10 fragment are potent modulators of attention in humans. In these studies the Nd component ('negative displacement') of the stimulus-evoked brain potential (event-related potential, ERP), which is a neurophysiological indicator of selective attention, proved most sensitive to effects of these peptides. The Nd decreased in amplitude linearly with logarithmically increasing doses of ACTH 4-10 applied. Here we report results complementing these previous findings by establishing a time course of the effects of ACTH 4-10 on human attention. In a double-blind cross-over study, attention performance on a dichotic listening task was tested in 18 healthy volunteers, after having received intravenously either placebo or 1 mg ACTH 4-10. Tests took place 0, 30, 90, 180, 330, 600 min, 24, 48 and 72 h after drug intake and took about 15 min. Each subject was tested on 4 of these occasions, selected according to a random schedule. During task performance ERPs to the different task stimuli were recorded. ERPs were used to determine the Nd (an indicator of controlled processing of stimuli which the subjects selectively attended to) and the mismatch negativity (MMN) reflecting automatic processing of stimulus deviance. ACTH 4-10 diminished the Nd significantly at 30 min after treatment administration. On none of the other occasions significant changes in Nd occurred. MMN was not affected by the peptide. The results indicate a short-term action of ACTH 4-10 on selective attention, which takes about 30 min to develop and does not last longer than 90 min after treatment.
以往的研究表明,促肾上腺皮质激素(ACTH)及其4 - 10片段是人类注意力的有效调节因子。在这些研究中,刺激诱发脑电位(事件相关电位,ERP)的Nd成分(“负向偏移”),作为选择性注意力的神经生理指标,被证明对这些肽的作用最为敏感。随着所施加的ACTH 4 - 10剂量呈对数增加,Nd的振幅呈线性下降。在此,我们通过确定ACTH 4 - 10对人类注意力影响的时间进程来报告补充这些先前发现的结果。在一项双盲交叉研究中,18名健康志愿者在静脉注射安慰剂或1毫克ACTH 4 - 10后,接受了双耳分听任务的注意力表现测试。测试在服药后0、30、90、180、330、600分钟、24、48和72小时进行,每次测试约15分钟。根据随机时间表,每个受试者在其中4个时间点接受测试。在任务执行期间,记录了针对不同任务刺激的ERP。ERP用于确定Nd(受试者选择性关注的刺激的受控加工指标)和反映刺激偏差自动加工的失配负波(MMN)。治疗给药后30分钟,ACTH 4 - 10显著降低了Nd。在其他任何时间点,Nd均未发生显著变化。MMN不受该肽的影响。结果表明,ACTH 4 - 10对选择性注意力有短期作用,这种作用约30分钟后显现,且在治疗后持续不超过90分钟。